The study is looking for women with hot flashes and night sweats and a BMI above 30. Mayo Clinic has the full eligibility rules and how to sign up.
Recap by typeshit. Post by Facebook on Facebook.
The review looks at concerns about misuse as demand for GLP-1 drugs grows, and points to how little evidence guides their use beyond approved conditions.
Researchers found self-reported GLP-1 use climbed from March 2024 to October 2025, mostly for weight loss, through channels insurance data may not capture.
A matched cohort study in Inflammatory Bowel Diseases found remission odds nearly six times higher on GLP-1 drugs, and weight loss alone didn't explain it.
She says women with endometriosis taking GLP-1 drugs tell her bloating, pain and fatigue feel better. These are patient reports, not trial results.
Trell argues a toned lower body comes from lean muscle, crediting weekly strength training and recovery fuel rather than Ozempic or peptides.
The FDA cleared Awiqli as the first weekly insulin for kids 10 and up with type 2 diabetes, and a CagriSema subgroup showed 25% weight loss in women.
Loading…